-
Mashup Score: 3URMC Heart Researchers Launch $27M ICD Study - 7 hour(s) ago
The study may decrease the use of implantable cardioverter defibrillators (ICD), as advances in medical therapies have improved outcomes for patients with heart failure.
Source: www.urmc.rochester.eduCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 76
In this prespecified pooled analysis of the STEP-HFpEF and STEP-HFpEF DM trials, semaglutide was superior to placebo in improving heart failure-related symptoms and physical limitations, and reducing bodyweight in participants with obesity-related heart failure with preserved ejection fraction. These effects were largely consistent across patient demographic and clinical characteristics. Semaglutide was well tolerated.
Source: www.thelancet.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 75
In this prespecified pooled analysis of the STEP-HFpEF and STEP-HFpEF DM trials, semaglutide was superior to placebo in improving heart failure-related symptoms and physical limitations, and reducing bodyweight in participants with obesity-related heart failure with preserved ejection fraction. These effects were largely consistent across patient demographic and clinical characteristics. Semaglutide was well tolerated.
Source: www.thelancet.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 128
AbstractBackgroundGuideline-directed medical therapy (GDMT) remains underutilized in patients with heart failure with reduced ejection fraction, leading to morbidity and mortality.ObjectivesThe Med…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 128
AbstractBackgroundGuideline-directed medical therapy (GDMT) remains underutilized in patients with heart failure with reduced ejection fraction, leading to morbidity and mortality.ObjectivesThe Med…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 128
AbstractBackgroundGuideline-directed medical therapy (GDMT) remains underutilized in patients with heart failure with reduced ejection fraction, leading to morbidity and mortality.ObjectivesThe Med…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 126
AbstractBackgroundGuideline-directed medical therapy (GDMT) remains underutilized in patients with heart failure with reduced ejection fraction, leading to morbidity and mortality.ObjectivesThe Med…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 4Growth differentiation factor-15 (GDF-15) and clinical outcomes in patients with chronic heart failure - 1 month(s) ago
Heart failure (HF) is associated with increased mortality and hospitalizations. Biomarkers have an important role in the early diagnosis of HF, as well as in prognosis assessment and monitoring response to treatment. Natriuretic peptides are the gold-standard biomarkers in HF.
Source: onlinejcf.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 21Medicare to Cover Wegovy When Patients Also Have Heart Disease - 1 month(s) ago
US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
Source: www.usnews.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 24Physiology and Clinical Utility of HeartMate Pump Parameters - 1 month(s) ago
There are an estimated 300,000 patients in the United States living with heart failure (HF) who may be eligible for advanced HF therapies, specifically left ventricular assist device (LVAD) or cardiac transplantation.1–3 Owing to limited organ availability and strict patient selection, only about 3000 patients underwent cardiac transplantation in 2019.4,5 Meanwhile, LVAD technology continues to improve significantly. According to the 2019 Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) report, the 1-year survival was 82%, but recent advances in pump technology with the HeartMate 3 (HM3; Abbott, Abbott Park, IL) have improved quantity, and quality of life for these patients.
Source: onlinejcf.comCategories: General Medicine News, CardiologistsTweet
RT @IlanGoldenberg2: URMC Heart Researchers Launch $27M ICD Study https://t.co/BalPrWQPxr